Pricing
Transparent ranges. Fixed scope. No hourly billing.
I publish starting numbers because you deserve to know roughly what a conversation costs before you have it. Your exact fee depends on scope, timeline, and what you actually need, but you should never have to guess what ballpark we are in.
Three principles I price by
These shape how every engagement gets scoped and billed.
- Engagements, not hours. I will not bill you for a clock. I scope a deliverable, name a fee, and finish.
- Fixed scope, fixed fee. Every engagement starts with a written scope and price. If the scope changes, we re-paper before any new work begins.
- Discovery is on me. The first 30-minute call is free. If I cannot help, I will tell you, and I will point you to someone who can.
Engagement structures
Most of my work falls into one of these. The figures below are honest starting points. Your exact fee is scoped on the free discovery call and fixed in writing before any work begins.
Discovery Call
Free · 30 minutesA direct conversation about what you are working on. Bring the question, the audit finding, the financial number that is not adding up, or just the sense that something is off. We will see if I can help.
- No deliverable, no follow-up obligation
- If I cannot help, I will tell you and refer you out
340B Program Review
From $12,000 · 4 to 6 weeksAn end-to-end review of your 340B program. Covered entity or grantee. In-house or contract pharmacy. You get an audit-style findings report, a prioritized fix list, and a 90-day plan you can execute without me.
- Eligibility and registration audit (OPAIS, grant alignment)
- Contract pharmacy and TPA performance review
- Buy-and-bill workflow, JW/JZ modifier capture, biosimilar conversion analysis
- Split-billing, mixed-use, GPO carve-out, orphan drug review
- Findings report plus 90-day prioritized fix list
Investment: From $12,000, fixed for the engagement. The exact fee is scoped to your program's size and entity type on the free discovery call. See what this covers.
Access & Reimbursement Assessment
From $9,000 · 3 to 5 weeksA current-state assessment of the referral-to-first-dose pathway: benefits investigation, prior authorization, assistance enrollment, and the handoffs between them. You get the delay points named, measured where the data exists, and a prioritized fix list.
- Referral-to-first-dose pathway mapping by therapeutic class
- Benefits investigation and prior authorization workflow review
- Patient assistance, copay, and foundation enrollment process review
- Access barrier measurement set your team can run monthly
- Prioritized fix list with owners and target metrics
Investment: From $9,000, scoped to site count and service line. See what this covers.
Strategic Advisory Retainer
From $4,000 / monthStanding access for pharmacy directors, VPs, and C-suite leaders who want a thinking partner on call. Strategy sessions, document reviews, hard-conversation prep, board-deck pressure-testing.
- Bi-weekly working sessions plus async availability
- Document and deck reviews (formulary, 340B, capital plans)
- Vendor and partnership evaluation
- 3-month minimum engagement, monthly thereafter
Investment: From $4,000 / month, scoped to depth and cadence. 3-month minimum, monthly thereafter.
Interim Pharmacy Director / Project Lead
From $18,000 / monthFull-time-equivalent leadership coverage during a director vacancy, turnaround, or major project. Drug diversion incident. USP 800 inspection failure. DSCSA non-compliance. Oncology service line crisis.
- On-site or hybrid leadership presence
- Direct ownership of identified workstreams
- Staff development and succession planning
- Defined exit criteria and handoff plan from day one
Investment: From $18,000 / month, scaled to scope and on-site requirement. Exit criteria defined from day one. See what this covers.
Manufacturer & Partner Advisory
Scoped per engagementAdvisory boards, provider-side reimbursement and coverage education for field and medical teams, oncology pathway and protocol review, and voice-of-the-customer input on institutional access barriers.
- Scoped by session, workshop, or defined advisory engagement
- Compensation set at fair market value and documented in writing
- Non-promotional and product-neutral by design
- Conflicts of interest disclosed in writing before work begins
Investment: Scoped per engagement and routed through your contracting and compliance process. Start a partner inquiry.
Pharmacy Leadership Coaching
$1,800 to $3,200 · 6 sessions / 90 daysOne-to-one advisory for student pharmacists, residency applicants, residents, and emerging pharmacy executives. A separate line of work from the institutional advisory above.
- Six 60-minute working sessions over 90 days
- Residency program and ranking strategy
- Letter of recommendation and letter of intent reviews
- CV and LinkedIn rewrite included
- Mock interview and offer-review support
- Async access between sessions
Investment: $1,800 to $3,200 flat, by stage and seniority. Locked in writing before the first session.
Want exact pricing for your situation?
Book the discovery call. We will talk through what you are actually trying to fix, and I will send you a written scope and fixed fee within two business days. No pressure, no hard sell.